Categories
|
Subjects
|
VHL Instance
|
|
Health Services |
Compulsory notification in cases of abuse and sexual exploitation of children and adolescents |
|
VHL, |
Nursing and Care |
Comunicação Científica em Enfermagem |
|
VHL, |
Social Determinants of Health |
Conditions of employment and health |
VHL Social Determinants of Health |
VHL, |
Geographic Regions |
Congo |
|
VHL, |
EVID@Easy |
Consider equity aspects for implementing options (interventions) |
|
VHL, |
EVID@Easy |
Consider ethical aspects for implementing options (interventions) |
|
VHL, |
Women's Health |
Contraceptives and migraine |
|
VHL, |
Health Promotion |
Control and prevention of influenza A |
Portal de Evidências em Saúde Pública |
VHL, |
Neglected Diseases |
Control of zoonoses Latin America and the Caribbean |
|
VHL, |
Metodology of Studies in Health |
Controlled clinical trials |
LILACS Portal |
VHL, |
Wounds and Injuries |
Controlled Clinical Trials for Hypertrophic Cicatrices and Keloid treatments |
|
VHL, |
COVID-19, Virus Diseases |
Coronavirus – COVID-19 |
|
VHL, |
COVID-19, Virus Diseases |
Coronavirus – COVID-19 |
|
VHL, |
COVID-19 |
Coronavirus – COVID-19 – Refugees |
|
VHL, |
Latin American and Caribbean Region |
Costa Rica |
|
VHL, |
WHO LMIC Country filters, Geographic Regions |
Cote D’ivoire |
|
VHL, |
Geographic Regions |
Côte d’Ivoire |
|
VHL, |
COVID-19 |
COVID -19 and Equity |
|
VHL, |
COVID-19 |
COVID -19 and public transport |
|
VHL, |
COVID-19 |
COVID -19 and School |
|
VHL, |
COVID-19 |
COVID -19 and Violence |
|
VHL, |
COVID-19, Communicable and Parasitic Diseases |
COVID-1 and Mucormycosis |
|
VHL, |
COVID-19, Communicable and Parasitic Diseases, WHO Library |
Covid-19 |
|
VHL, |
COVID-19 |
COVID-19 -Food Insecurity |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 -Tobacco Use Disorder |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Children e Adolescent |
|
VHL, |
COVID-19 |
COVID-19 – Access to drugs for the treatment of HIV, tuberculosis, hepatitis and cancer |
|
VHL, |
COVID-19 |
COVID-19 – Access to other essential medicines: blood supply for transfusion and the COVID-19 pandemic |
|
VHL, |
COVID-19 |
COVID-19 – Actions in the communities |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Antiretroviral Agents |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Biomedical research |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Biosafety |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Chloroquine / Hydroxychloroquine |
|
VHL, |
COVID-19 |
COVID-19 – Communicable Diseases |
|
VHL, |
COVID-19 |
COVID-19 – Communication and information to combat the Infodemic |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Complications |
|
VHL, |
COVID-19 |
COVID-19 – Development of skills in Public Health |
|
VHL, |
COVID-19, Telehealth |
COVID-19 – Digital health: Telemedicine and information systems |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Effectiveness of the use of masks in disease prevention |
|
VHL, |
COVID-19 |
COVID-19 – Effects of the pandemic on mental health |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Emergency strategies |
|
VHL, |
COVID-19, Health Surveillance and Regulation |
COVID-19 – Epidemiological surveillance for decision making |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Epidemiology e Epidemiological studies |
|
VHL, |
COVID-19, Health Promotion |
COVID-19 – First level of health care and human resources |
|
VHL, |
COVID-19 |
COVID-19 – Government health response |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – hand hygiene |
|
VHL, |
COVID-19, Health Policy |
COVID-19 – Health governance |
|
VHL, |
COVID-19 |
COVID-19 – Health life expectancy |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Health, social and economic impacts |
|
VHL, |
COVID-19 |
COVID-19 – Immunization |
|
VHL, |
COVID-19 |
COVID-19 – Inequity and ethnicity |
|
VHL, |
COVID-19 |
COVID-19 – Infancy, childhood and adolescence |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Lessons learned |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Mortality |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Neoplasms |
|
VHL, |
COVID-19, Chronic and Non Communicable Diseases |
COVID-19 – Noncommunicable Diseases and inequality |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Nursing |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Nutrition / Food |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Pediatric population and pregnant women |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Pediatric population including-Diagnosis, epidemiology, treatment and laboratory and imaging exams |
|
VHL, |
COVID-19 |
COVID-19 – Performance of the Region in 2021 and outlook for 2022 |
|
VHL, |
COVID-19 |
COVID-19 – Pregnancy |
|
VHL, |
Virus Diseases |
COVID-19 – Preparedness and Response |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Prevention and Control |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Prognosis |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Reinfection |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Sequelae and rehabilitation |
|
VHL, |
COVID-19 |
COVID-19 – Substance abuse |
|
VHL, |
COVID-19, Mental Health |
COVID-19 – Suicide |
|
VHL, |
COVID-19 |
COVID-19 – Training of Human Resources in Health during the COVID-19 pandemic |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Transmission and Diagnosis |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Treatment |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 – Tuberculosis |
|
VHL, |
Universal Coverage of Health, COVID-19 |
COVID-19 – Universal Coverage |
|
VHL, |
COVID-19 |
COVID-19 – Vaccination, Hospitalizations and Mortality Rate |
|
VHL, |
COVID-19 |
COVID-19 – Vaccines for SARS CoV-2 |
|
VHL, |
COVID-19, Health Services |
COVID-19 and Health Services |
|
VHL, |
COVID-19 |
COVID-19 and Mental Health |
|
n/d |
COVID-19 |
COVID-19 and Senior |
|
VHL, |
COVID-19 |
COVID-19 and Transplantation |
|
VHL, |
COVID-19, Virus Diseases |
COVID-19 and Vaccines |
|
VHL, |
COVID-19 |
COVID-19 and Vulnerable Populations |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Case report |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Clinical practice guide |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Cohort Study |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Controlled clinical trial |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Diagnostic study |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Etiology study |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Evaluation studies |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Evidence synthesis |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Experimental Studies |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Health economic evaluation |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Health technology assessment |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Incidence studies |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Long Covid |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Observational study |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Prevalence studies |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Prognostic study |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Qualitative research |
|
VHL, |
COVID-19, Metodology of Studies in Health |
Covid-19 Database Randomized controlled trial |
|
VHL, |